BC Extra | Jun 16, 2016
Financial News

Antibiotic play Allecra raises EUR 22M

Allecra Therapeutics GmbH (Lorrach, Germany) raised EUR 22 million ($24.8 million) in an untranched series B round led by new investor Delos Capital. Existing investors Forbion Capital Partners, Edmond de Rothschild Investment Partners, EMBL Ventures...
Items per page:
1 - 1 of 1